Anika Therapeutics Inc (ANIK) returns
Anika Therapeutics returns over 10 years
$1,000 invested in Anika Therapeutics ten years ago was worth $487.21 at the close on October 30, 2026, with dividends reinvested: an average return of -6.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +6.6% | — | $1,066 | -0.9% |
| 3 months | +15.9% | — | $1,159 | +2.1% |
| Year to date | +118.0% | — | $2,180 | +11.7% |
| 1 year | +114.2% | — | $2,142 | +12.4% |
| 3 years | +10.3% | +3.3% | $1,103 | +88.5% |
| 5 years | -49.7% | -12.8% | $503.00 | +76.0% |
| 10 years | -51.3% | -6.9% | $487.21 | +316.6% |
Anika Therapeutics return by calendar year
| Year | ANIK | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +118.0% | +11.7% | +106.3% |
| 2025 | -41.6% | +17.7% | -59.3% |
| 2024 | -27.4% | +24.9% | -52.2% |
| 2023 | -23.4% | +26.2% | -49.6% |
| 2022 | -17.4% | -18.2% | +0.8% |
| 2021 | -20.8% | +28.7% | -49.6% |
| 2020 | -12.7% | +18.4% | -31.1% |
| 2019 | +54.3% | +31.2% | +23.0% |
| 2018 | -37.7% | -4.6% | -33.1% |
| 2017 | +10.1% | +21.7% | -11.6% |
| 2016 | +28.3% | +12.0% | +16.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ANIK financials · ANIK valuation
No forecast, no recommendation. This page describes Anika Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.